177 related articles for article (PubMed ID: 38310566)
1. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
[TBL] [Abstract][Full Text] [Related]
2. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of salivary miR-3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus.
Farshbaf A; Mohajertehran F; Aghaee-Bakhtiari SH; Ayatollahi H; Douzandeh K; Pakfetrat A; Mohtasham N
Clin Exp Dent Res; 2024 Apr; 10(2):e877. PubMed ID: 38481355
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus - a short report.
Mehdipour M; Shahidi M; Manifar S; Jafari S; Mashhadi Abbas F; Barati M; Mortazavi H; Shirkhoda M; Farzanegan A; Elmi Rankohi Z
Cell Oncol (Dordr); 2018 Jun; 41(3):329-334. PubMed ID: 29480379
[TBL] [Abstract][Full Text] [Related]
8. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.
Gholizadeh N; Emami Razavi A; Mohammadpour H; Tavakol F; Sheykhbahaei N
Mol Biol Rep; 2020 Feb; 47(2):1223-1232. PubMed ID: 31828562
[TBL] [Abstract][Full Text] [Related]
9. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
10. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing.
Yang Q; Guo B; Sun H; Zhang J; Liu S; Hexige S; Yu X; Wang X
Oncol Rep; 2017 Apr; 37(4):2355-2365. PubMed ID: 28259920
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
12. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
Sun L; Liu L; Fu H; Wang Q; Shi Y
Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
[TBL] [Abstract][Full Text] [Related]
13. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
[TBL] [Abstract][Full Text] [Related]
15. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
16. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
Momen-Heravi F; Trachtenberg AJ; Kuo WP; Cheng YS
J Dent Res; 2014 Jul; 93(7 Suppl):86S-93S. PubMed ID: 24718111
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
[TBL] [Abstract][Full Text] [Related]
18. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
19. Salivary level of microRNA-146a and microRNA-155 biomarkers in patients with oral lichen planus versus oral squamous cell carcinoma.
Mehdipour M; Shahidi M; Anbari F; Mirzaei H; Jafari S; Kholghi A; Lotfi E; Manifar S; Mashhadiabbas F
BMC Oral Health; 2023 Jun; 23(1):433. PubMed ID: 37386382
[TBL] [Abstract][Full Text] [Related]
20. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
